Author

Wenna Nie

Observed name: Nie, Wenna

Institution: China-US (Henan) Hormel Cancer Institute

Observed institutions: Chongqing University, China-US (Henan) Hormel Cancer Institute

ORCID: 0000-0003-4081-9670

Observed ORCID: 0000-0003-4081-9670

OpenAlex ID: A5046057586

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

2023 · Penglei Wang, Xuechao Jia, et al. · Signal Transduction and Targeted Therapy · 104

PDF

CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction

2019 · Yiu To Yeung, Suyu Fan, et al. · Carcinogenesis · 58

Advanced mass spectrometry‐based multi‐omics technologies for exploring the pathogenesis of hepatocellular carcinoma

2014 · Wenna Nie, Leyu Yan, et al. · Mass Spectrometry Reviews · 48

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

2021 · Xuechao Jia, Chuntian Huang, et al. · Journal of Experimental & Clinical Cancer Research · 43

PDF

A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC

2022 · Yunfeng Gao, Ming Jiang, et al. · Oncogene · 29

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets

2024 · Dengyun Zhao, Yaping Guo, et al. · JCI Insight · 23

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

2023 · Xuechao Jia, Penglei Wang, et al. · Journal of Experimental & Clinical Cancer Research · 23

PDF

Metabolic phenotyping of the Yersinia high-pathogenicity island that regulates central carbon metabolism

2015 · Leyu Yan, Wenna Nie, et al. · The Analyst · 20

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

2023 · Xiaomeng Xie, Kyle Vaughn Laster, et al. · Cellular and Molecular Life Sciences · 19

PDF

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma

2024 · Liting Zhou, Jie Tian, et al. · Cancer Research · 18

Prediction and Characterisation of the System Effects of Aristolochic Acid: A Novel Joint Network Analysis towards Therapeutic and Toxicological Mechanisms

2015 · Wenna Nie, Yana Lv, et al. · Scientific Reports · 14

PDF

Ms-Based Metabolomics Facilitates the Discovery of In Vivo Functional Small Molecules with a Diversity of Biological Contexts

2013 · Leyu Yan, Wenna Nie, et al. · Future Medicinal Chemistry · 13

Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathway

2024 · Mangaladoss Fredimoses, Pan Li, et al. · Bioorganic Chemistry · 9

RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters

2025 · Huifang Wei, Dengyun Zhao, et al. · Advanced Science · 8

PDF

Mass spectrometry based molecular profile dissects the complexity of traditional Chinese medicine

2015 · Wenhu Liu, Xiaojuan Guo, et al. · Analytical Methods · 5

CHI-KAT8i5 suppresses ESCC tumor growth by inhibiting KAT8-mediated c-Myc stability

2025 · Dandan Zhang, Ming Jiang, et al. · Cell Reports · 4

LIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1

2025 · Jie Tian, Shihui Liu, et al. · Oncogene · 3

PDF

AHCYL1 mediates the tumor-promoting effect of PREX2 in non-small cell lung carcinoma

2025 · Mingjuan Lei, Yiu To Yeung, et al. · Theranostics · 2

PDF

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo

2022 · Fayang Ma, Fangfang Liu, et al. · Journal of Cancer · 1

PDF

SDCBP competes with CBL to stabilize PES1 and promote c-Myc translation in ESCC tumorigenesis

2026 · Nan Xiao, Qian Luo, et al. · Cell Reports

Figure S5+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma